Vaishali Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹23 crore and net profit of ₹1.49 crore for the June 2026 quarter.
Vaishali Pharma (NSE: VAISHALI) closed at ₹6.63 on 20 Nov 2026. Its market capitalisation is ₹90 crore and it trades at 21.1 times earnings.
Incorporated in 1989, Vaishali Pharma Ltd does marketing of pharmaceutical products including active pharmaceutical ingredients
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.